REFERENCE
MHRA.Prasugrel (Efient): rare but serious hypersensitivity reactions. Drug Safety Update 4: No. 10, May 2011
Rights and permissions
About this article
Cite this article
The UK MHRA is cautioning prescribers to be aware of the potential risk of serious hypersensitivity reactions with prasugrel. React. Wkly. 1352, 2 (2011). https://doi.org/10.2165/00128415-201113520-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-201113520-00004